ArticleBosnian journal of basic medical sciences2022

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.

Selin Aktürk Esen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.